Sherif M Badawy
Overview
Explore the profile of Sherif M Badawy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
2053
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Palermo T, Srinakarin K, Zhou C, Lalloo C, Dampier C, Zempsky W, et al.
Pain
. 2025 Mar;
PMID: 40085012
Pain is the hallmark symptom of sickle cell disease (SCD). By adolescence, 20% of youth with SCD develop chronic SCD pain. Our randomized controlled trial found significant reductions in pain...
2.
Hildenbrand A, Mara C, Murphy B, Hood A, Johnson Y, Shook L, et al.
Pediatr Blood Cancer
. 2025 Mar;
:e31639.
PMID: 40051208
Background: Guidelines recommend that hydroxyurea be offered to children with sickle cell disease (SCD) as early as 9 months of age using shared decision-making. To help clinicians implement shared decision-making...
3.
Yang M, Singh R, Haugen M, Duff A, Shoop J, Morgan E, et al.
Eur J Haematol
. 2025 Jan;
PMID: 39832489
Background: Low 6-mercaptopurine (6-MP) adherence (< 95%) is associated with increased relapse in pediatric acute lymphoblastic leukemia (ALL). Stronger habit has been associated with higher adherence. We examined the relationship...
4.
Fei-Zhang D, Wu E, Stanisic A, Hou L, Platanias L, Ansell S, et al.
Blood Adv
. 2025 Jan;
PMID: 39808792
Although social determinants of health (SDoH) investigations have shown limited analyses of socioeconomic and race-ethnic status on certain hematologic malignancies, the impact of factors beyond those across a fuller scope...
5.
Tantoco A, Badawy S, Lee C, Merz J, Steed M, Kluk M, et al.
Pediatr Hematol Oncol
. 2024 Dec;
42(2):69-78.
PMID: 39659207
Hospitalized patients with sickle cell disease (SCD) may use opioid medications for both acute and chronic pain management. Use of these medications may unintentionally generate diagnostic codes for opioid misuse...
6.
OBrien J, Jonassaint C, Parchuri E, Lalama C, Badawy S, Hamm M, et al.
J Pain
. 2024 Oct;
26:104720.
PMID: 39447944
Painimation, a novel digital pain assessment tool, allows patients to communicate their pain quality, intensity, and location using abstract animations (painimations) and a paintable body image. This study determined the...
7.
Jonassaint C, Lalama C, Carroll C, Badawy S, Hamm M, Stinson J, et al.
Blood Adv
. 2024 Oct;
8(24):6257-6266.
PMID: 39374587
Despite the burden of chronic pain in sickle cell disease (SCD), nonpharmacological approaches remain limited. This multisite, randomized trial compared digital cognitive behavioral therapy (CBT) with a digital pain/SCD education...
8.
Kahn J, Brazauskas R, Bo-Subait S, Buchbinder D, Hamilton B, Schoemans H, et al.
Lancet Child Adolesc Health
. 2024 Sep;
8(10):740-750.
PMID: 39217999
Background: Continued advances in haematopoietic cell transplantation (HCT) for children with non-malignant diseases (NMDs) have led to a growing population of survivors in whom late occurring toxic effects remain a...
9.
McLoughlin D, Moreno Echevarria F, Badawy S
JMIR Cancer
. 2024 Aug;
10:e56935.
PMID: 39187430
Oral chemotherapy is commonly prescribed, and by using decision aids (DAs), clinicians can facilitate shared decision-making (SDM) to align treatment choices with patient goals and values. Although products exist commercially,...
10.
Nakano T, Grimes A, Klaassen R, Lambert M, Neunert C, Rothman J, et al.
Blood Adv
. 2024 Jul;
8(19):5112-5117.
PMID: 39059013
There are no agreed upon terminology to define "refractory" pediatric immune thrombocytopenia (ITP). Guidelines are therefore limited to arbitrary and outdated definitions. The Pediatric ITP Consortium of North America held...